龍建股份(600853.SH):聯合體中標3個項目
格隆匯 12 月 29日丨龍建股份(600853.SH)公佈,近日,公司與重慶市市政設計研究院有限公司(“重慶市政設計院”)、公司子公司黑龍江省龍建路橋第四工程有限公司(“四公司”)、公司孫公司遂寧龍建路橋建設工程有限公司(“遂寧龍建公司”)組成的聯合體(“聯合體”)收到招標人遂寧市新城建設投資有限公司發來的中標通知書:
聯合體成為遂寧河東新區香林路北延線(二期)道路項目(樂魚橋、月詩橋、香林橋、蜀韻橋)、遂寧市河東新區二期生態資源保護項目(生態走廊工程)、遂寧市河東新區湖域水利項目設計-施工總承包中標人。中標價:設計費約175.11萬元(下浮率2.88%);建安工程費約4.83億元(下浮率6.01%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.